These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38880414)

  • 1. FET PET-based target volume delineation for the radiotherapy of glioblastoma: A pictorial guide to help overcome methodological pitfalls.
    Holzgreve A; Nitschmann A; Maier SH; Büttner M; Schönecker S; Marschner SN; Fleischmann DF; Corradini S; Belka C; la Fougère C; Bodensohn R; Albert NL; Niyazi M
    Radiother Oncol; 2024 Sep; 198():110386. PubMed ID: 38880414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastoma.
    Hayes AR; Jayamanne D; Hsiao E; Schembri GP; Bailey DL; Roach PJ; Khasraw M; Newey A; Wheeler HR; Back M
    Pract Radiat Oncol; 2018; 8(4):230-238. PubMed ID: 29730279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) - protocol of a randomized phase II trial (NOA 10/ARO 2013-1).
    Oehlke O; Mix M; Graf E; Schimek-Jasch T; Nestle U; Götz I; Schneider-Fuchs S; Weyerbrock A; Mader I; Baumert BG; Short SC; Meyer PT; Weber WA; Grosu AL
    BMC Cancer; 2016 Oct; 16(1):769. PubMed ID: 27716184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma.
    Poulsen SH; Urup T; Grunnet K; Christensen IJ; Larsen VA; Jensen ML; Af Rosenschöld PM; Poulsen HS; Law I
    Eur J Nucl Med Mol Imaging; 2017 Mar; 44(3):373-381. PubMed ID: 27554774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated-boost IMRT or 3-D-CRT using FET-PET based auto-contoured target volume delineation for glioblastoma multiforme--a dosimetric comparison.
    Piroth MD; Pinkawa M; Holy R; Stoffels G; Demirel C; Attieh C; Kaiser HJ; Langen KJ; Eble MJ
    Radiat Oncol; 2009 Nov; 4():57. PubMed ID: 19930657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [F-DOPA PET/MR based target definiton in the 3D based radiotherapy treatment of glioblastoma multiforme patients. First Hungarian experiences].
    Sipos D; Tóth Z; Lukács G; Bajzik G; Hadjiev J; Cselik Z; Repa I; Kovács Á
    Ideggyogy Sz; 2019 May; 72(5-6):209-215. PubMed ID: 31241266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FET-PET for malignant glioma treatment planning.
    Niyazi M; Geisler J; Siefert A; Schwarz SB; Ganswindt U; Garny S; Schnell O; Suchorska B; Kreth FW; Tonn JC; Bartenstein P; la Fougère C; Belka C
    Radiother Oncol; 2011 Apr; 99(1):44-8. PubMed ID: 21458093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of FET-PET imaging for target volume definition in patients with gliomas treated with conformal radiotherapy.
    Rieken S; Habermehl D; Giesel FL; Hoffmann C; Burger U; Rief H; Welzel T; Haberkorn U; Debus J; Combs SE
    Radiother Oncol; 2013 Dec; 109(3):487-92. PubMed ID: 23953407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [F-18]-fluorodeoxyglucose positron emission tomography for targeting radiation dose escalation for patients with glioblastoma multiforme: clinical outcomes and patterns of failure.
    Douglas JG; Stelzer KJ; Mankoff DA; Tralins KS; Krohn KA; Muzi M; Silbergeld DL; Rostomily RC; Scharnhorst J; Spence AM
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):886-91. PubMed ID: 16242251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence pattern after [(18)F]fluoroethyltyrosine-positron emission tomography-guided radiotherapy for high-grade glioma: a prospective study.
    Weber DC; Casanova N; Zilli T; Buchegger F; Rouzaud M; Nouet P; Vees H; Ratib O; Dipasquale G; Miralbell R
    Radiother Oncol; 2009 Dec; 93(3):586-92. PubMed ID: 19782417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relapse patterns after radiochemotherapy of glioblastoma with FET PET-guided boost irradiation and simulation to optimize radiation target volume.
    Piroth MD; Galldiks N; Pinkawa M; Holy R; Stoffels G; Ermert J; Mottaghy FM; Shah NJ; Langen KJ; Eble MJ
    Radiat Oncol; 2016 Jun; 11():87. PubMed ID: 27342976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography for radiation treatment planning.
    Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
    Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-irradiation tumour volumes defined by MRI and dual time-point FET-PET for the prediction of glioblastoma multiforme recurrence: A prospective study.
    Harat M; Małkowski B; Makarewicz R
    Radiother Oncol; 2016 Aug; 120(2):241-7. PubMed ID: 27378734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast Activation Protein (FAP) specific PET for advanced target volume delineation in glioblastoma.
    Windisch P; Röhrich M; Regnery S; Tonndorf-Martini E; Held T; Lang K; Bernhardt D; Rieken S; Giesel F; Haberkorn U; Debus J; Adeberg S
    Radiother Oncol; 2020 Sep; 150():159-163. PubMed ID: 32598977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of [11C]methionine positron emission tomography for target definition of glioblastoma multiforme in radiation therapy planning.
    Matsuo M; Miwa K; Tanaka O; Shinoda J; Nishibori H; Tsuge Y; Yano H; Iwama T; Hayashi S; Hoshi H; Yamada J; Kanematsu M; Aoyama H
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):83-9. PubMed ID: 21095072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of multi-parametric PET and MRI for prediction of tumour recurrence in patients with glioblastoma.
    Lundemann M; Munck Af Rosenschöld P; Muhic A; Larsen VA; Poulsen HS; Engelholm SA; Andersen FL; Kjær A; Larsson HBW; Law I; Hansen AE
    Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):603-613. PubMed ID: 30276440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delineation and agreement of FET PET biological volumes in glioblastoma: results of the nuclear medicine credentialing program from the prospective, multi-centre trial evaluating FET PET In Glioblastoma (FIG) study-TROG 18.06.
    Barry N; Francis RJ; Ebert MA; Koh ES; Rowshanfarzad P; Hassan GM; Kendrick J; Gan HK; Lee ST; Lau E; Moffat BA; Fitt G; Moore A; Thomas P; Pattison DA; Akhurst T; Alipour R; Thomas EL; Hsiao E; Schembri GP; Lin P; Ly T; Yap J; Kirkwood I; Vallat W; Khan S; Krishna D; Ngai S; Yu C; Beuzeville S; Yeow TC; Bailey D; Cook O; Whitehead A; Dykyj R; Rossi A; Grose A; Scott AM
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3970-3981. PubMed ID: 37563351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator.
    Bolcaen J; Descamps B; Boterberg T; Vanhove C; Goethals I
    J Vis Exp; 2017 Dec; (130):. PubMed ID: 29364211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade glioma.
    Weber DC; Zilli T; Buchegger F; Casanova N; Haller G; Rouzaud M; Nouet P; Dipasquale G; Ratib O; Zaidi H; Vees H; Miralbell R
    Radiat Oncol; 2008 Dec; 3():44. PubMed ID: 19108742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilizing 18F-fluoroethyl-l-tyrosine positron emission tomography in high grade glioma for radiation treatment planning in patients with contraindications to MRI.
    Jaymanne DT; Kaushal S; Chan D; Schembri G; Brazier D; Bailey D; Wheeler H; Back M
    J Med Imaging Radiat Oncol; 2018 Feb; 62(1):122-127. PubMed ID: 28980392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.